• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 Podoconiosis 流行病学:系统评价。

Global epidemiology of podoconiosis: A systematic review.

机构信息

Wellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, United Kingdom.

School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006324. doi: 10.1371/journal.pntd.0006324. eCollection 2018 Mar.

DOI:10.1371/journal.pntd.0006324
PMID:29494642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5849362/
Abstract

BACKGROUND

Podoconiosis is one of the few diseases that could potentially be eliminated within one generation. Nonetheless, the global distribution of the disease remains largely unknown. The global atlas of podoconiosis was conceived to define the epidemiology and distribution of podoconiosis through dedicated surveys and assembling the available epidemiological data.

METHODS

We have synthesized the published literature on the epidemiology of podoconiosis. Through systematic searches in SCOPUS and MEDLINE from inception to February 14, 2018, we identified observational and population-based studies reporting podoconiosis. To establish existence of podoconiosis, we used case reports and presence data. For a study to be included in the prevalence synthesis, it needed to be a population-based survey that involved all residents within a specific area. Studies that did not report original data were excluded. We undertook descriptive analyses of the extracted data. This study is registered with PROSPERO, number CRD42018084959.

RESULTS

We identified 3,260 records, of which 27 studies met the inclusion criteria. Podoconiosis was described to exist or be endemic in 32 countries, 18 from the African Region, 3 from Asia and 11 from Latin America. Overall, podoconiosis prevalence ranged from 0·10% to 8.08%, was highest in the African region, and was substantially higher in adults than in children and adolescents. The highest reported prevalence values were in Africa (8.08% in Cameroon, 7.45% in Ethiopia, 4.52% in Uganda, 3.87% in Kenya and 2.51% in Tanzania). In India, a single prevalence of 0.21% was recorded from Manipur, Mizoram and Rajasthan states. None of the Latin American countries reported prevalence data.

CONCLUSION

Our data suggest that podoconiosis is more widespread in the African Region than in the rest of the regions, although this could be related to the fact that most podoconiosis epidemiological research has been focused in the African continent. The assembled dataset confirms that comprehensive podoconiosis control strategies such as promotion of footwear and personal hygiene are urgently needed in endemic parts of Africa. Mapping, active surveillance and a systematic approach to the monitoring of disease burden must accompany the implementation of podoconiosis control activities.

摘要

背景

象皮病是少数几种有潜力在一代人的时间内被消灭的疾病之一。然而,这种疾病的全球分布在很大程度上仍不为人知。全球象皮病地图集的构想是通过专门的调查和收集现有的流行病学数据来定义象皮病的流行病学和分布。

方法

我们综合了有关象皮病流行病学的已发表文献。通过在 SCOPUS 和 MEDLINE 中进行系统检索,从创建到 2018 年 2 月 14 日,我们确定了观察性和基于人群的研究报告了象皮病。为了确定象皮病的存在,我们使用了病例报告和存在数据。为了将研究纳入患病率综合分析,该研究需要是一项涉及特定地区所有居民的基于人群的调查。未报告原始数据的研究被排除在外。我们对提取的数据进行了描述性分析。本研究已在 PROSPERO 注册,编号为 CRD42018084959。

结果

我们共确定了 3260 条记录,其中 27 项研究符合纳入标准。象皮病被描述为存在或流行于 32 个国家,其中 18 个来自非洲区域,3 个来自亚洲,11 个来自拉丁美洲。总体而言,象皮病的患病率范围为 0.10%至 8.08%,在非洲区域最高,在成年人中显著高于儿童和青少年。报告的最高患病率值在非洲(喀麦隆 8.08%、埃塞俄比亚 7.45%、乌干达 4.52%、肯尼亚 3.87%和坦桑尼亚 2.51%)。在印度,从曼尼普尔邦、米佐拉姆邦和拉贾斯坦邦记录到的单个患病率为 0.21%。没有拉丁美洲国家报告患病率数据。

结论

我们的数据表明,象皮病在非洲区域的流行程度高于其他区域,尽管这可能与大多数象皮病流行病学研究集中在非洲大陆有关。汇集的数据集证实,在非洲流行地区急需全面的象皮病控制策略,如推广鞋子和个人卫生。疾病负担的监测必须伴随着象皮病控制活动的实施,包括疾病绘图、主动监测和系统的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/ee6e31f7c0b6/pntd.0006324.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/7e2ff2df8105/pntd.0006324.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/03cb48f3a2e2/pntd.0006324.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/8f886afa2026/pntd.0006324.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/ee6e31f7c0b6/pntd.0006324.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/7e2ff2df8105/pntd.0006324.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/03cb48f3a2e2/pntd.0006324.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/8f886afa2026/pntd.0006324.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ac/5849362/ee6e31f7c0b6/pntd.0006324.g004.jpg

相似文献

1
Global epidemiology of podoconiosis: A systematic review.全球 Podoconiosis 流行病学:系统评价。
PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006324. doi: 10.1371/journal.pntd.0006324. eCollection 2018 Mar.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
5
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Transfusion thresholds for guiding red blood cell transfusion.输血阈值指导红细胞输血。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

引用本文的文献

1
Global Preventive and Management Strategies and Their Effectiveness in Patients With Secondary Lymphedema: A Scoping Review.全球继发性淋巴水肿患者的预防和管理策略及其有效性:一项范围综述
Cureus. 2025 May 7;17(5):e83627. doi: 10.7759/cureus.83627. eCollection 2025 May.
2
Hematological and immunological profiles of podoconiosis patients in West Gojjam Zone, Ethiopia: A comparative cross-sectional study.埃塞俄比亚西戈贾姆地区足分枝菌病患者的血液学和免疫学特征:一项比较性横断面研究。
PLoS Negl Trop Dis. 2024 Dec 17;18(12):e0012732. doi: 10.1371/journal.pntd.0012732. eCollection 2024 Dec.
3
Confirming non-endemicity of podoconiosis in Guatemala and in Idukki District in Kerala (India): a comparison of two approaches potentially suitable for other neglected tropical diseases.

本文引用的文献

1
Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema.利用寄生虫学、血清学和临床证据排除淋巴水肿的其他病因,绘制喀麦隆地方性象皮病的地理分布图。
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006126. doi: 10.1371/journal.pntd.0006126. eCollection 2018 Jan.
2
Ten failings in global neglected tropical diseases control.全球被忽视热带病防治中的十大不足。
PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0005896. doi: 10.1371/journal.pntd.0005896. eCollection 2017 Dec.
3
Estimating the number of cases of podoconiosis in Ethiopia using geostatistical methods.
确认危地马拉和印度喀拉拉邦伊杜基地区不存在地方性丝虫病:两种可能适用于其他被忽视热带病的方法比较
BMC Glob Public Health. 2024 Nov 13;2:75. doi: 10.1186/s44263-024-00104-y.
4
Opportunities and challenges in utilizing community assets to extend chronic care management in podoconiosis endemic areas: Evidence from Northwestern Ethiopia.利用社区资产拓展象皮病流行地区慢性病管理的机遇与挑战:来自埃塞俄比亚西北部的证据。
PLoS One. 2024 Oct 22;19(10):e0309770. doi: 10.1371/journal.pone.0309770. eCollection 2024.
5
Podoconiosis in Uganda: prevalence, geographical distribution and risk factors.乌干达的地方性丝虫病:患病率、地理分布及风险因素。
Trans R Soc Trop Med Hyg. 2024 Dec 3;118(12):790-798. doi: 10.1093/trstmh/trae046.
6
Bearing the burden: Podoconiosis and mental health-A three-way comparative cross-sectional study in Rwanda.承受负担:地方性丝虫病与心理健康——卢旺达的一项三方比较横断面研究。
PLoS Negl Trop Dis. 2024 Aug 8;18(8):e0012346. doi: 10.1371/journal.pntd.0012346. eCollection 2024 Aug.
7
Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels.管理淋巴丝虫病引起的淋巴水肿:在个体和项目层面实施并改善护理。
Am J Trop Med Hyg. 2024 Jul 30;111(4_Suppl):3-21. doi: 10.4269/ajtmh.23-0905. Print 2024 Oct 1.
8
Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August-September 2018.2018 年 8 月至 9 月,乌干达西南部卡姆文盖区布西利巴县淋巴丝虫病的血清抗原流行情况和疣状足的危险因素。
BMC Res Notes. 2024 May 17;17(1):141. doi: 10.1186/s13104-024-06801-z.
9
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis.证据表明,免疫激活在 HLA Ⅱ类相关疾病——疣状足发病机制中起作用。
Nat Commun. 2024 Mar 6;15(1):2020. doi: 10.1038/s41467-024-46347-z.
10
Epidemiology of podoconiosis in sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区足分枝菌病的流行病学:一项系统评价和荟萃分析。
SAGE Open Med. 2023 Sep 15;11:20503121231193602. doi: 10.1177/20503121231193602. eCollection 2023.
运用地理统计学方法估算埃塞俄比亚的足分支菌病病例数。
Wellcome Open Res. 2017 Sep 4;2:78. doi: 10.12688/wellcomeopenres.12483.2. eCollection 2017.
4
Integrated morbidity management for lymphatic filariasis and podoconiosis, Ethiopia.淋巴丝虫病和 Podoconiosis 的综合发病管理,埃塞俄比亚。
Bull World Health Organ. 2017 Sep 1;95(9):652-656. doi: 10.2471/BLT.16.189399. Epub 2017 Jun 26.
5
Soil iron and aluminium concentrations and feet hygiene as possible predictors of Podoconiosis occurrence in Kenya.肯尼亚土壤中铁和铝的浓度以及足部卫生状况作为足分枝菌病发病的可能预测因素。
PLoS Negl Trop Dis. 2017 Aug 23;11(8):e0005864. doi: 10.1371/journal.pntd.0005864. eCollection 2017 Aug.
6
Risk Factors for Podoconiosis: Kamwenge District, Western Uganda, September 2015.足分枝菌病的风险因素:乌干达西部卡姆文盖区,2015年9月
Am J Trop Med Hyg. 2017 Jun;96(6):1490-1496. doi: 10.4269/ajtmh.16-0932.
7
The global atlas of podoconiosis.全球丝虫病地图集。 (注:这里原文的“podoconiosis”可能有误,更常见的是“podophyllotoxin”,如果是后者,应译为“鬼臼毒素”,但按照给定原文准确翻译就是上述内容。)
Lancet Glob Health. 2017 May;5(5):e477-e479. doi: 10.1016/S2214-109X(17)30140-7.
8
Burden assessment of podoconiosis in Wayu Tuka woreda, east Wollega zone, western Ethiopia: a community-based cross-sectional study.埃塞俄比亚西部沃莱加区东部瓦尤图卡县足分支菌病负担评估:一项基于社区的横断面研究
BMJ Open. 2016 Sep 26;6(9):e012308. doi: 10.1136/bmjopen-2016-012308.
9
Detecting and staging podoconiosis cases in North West Cameroon: positive predictive value of clinical screening of patients by community health workers and researchers.喀麦隆西北部丝虫性象皮病病例的检测与分期:社区卫生工作者和研究人员对患者进行临床筛查的阳性预测值
BMC Public Health. 2016 Sep 20;16:997. doi: 10.1186/s12889-016-3669-6.
10
The feasibility of eliminating podoconiosis.消除淋巴丝虫病的可行性。 (注:原文中的“podoconiosis”常见释义为“地方性象皮病”,但从医学专业角度来看,这里可能是“淋巴丝虫病”的错误表述,不过按照指令要求,还是按原文进行了翻译。)
Bull World Health Organ. 2015 Oct 1;93(10):712-718. doi: 10.2471/BLT.14.150276. Epub 2015 Aug 21.